Disruption of the C/ebp Alpha Gene in Adult Mouse Liver

Overview

Journal Mol Cell Biol

Specialty Cell Biology

Date 1997 Oct 7

PMID 9315660

Citations 54

Authors

Y H Lee

B Sauer

P F Johnson

F J Gonzalez

Affiliations

Soon will be listed here.

Abstract

The liver-enriched transcription factor C/EBP alpha has been implicated in the regulation of numerous liver-specific genes. It was previously reported that mice carrying a homozygous null mutation at the c/ebp alpha locus died as neonates due to the absence of hepatic glycogen and the resulting hypoglycemia. However, the lethal phenotype precluded further analysis of the role of C/EBP alpha in hepatic gene regulation in adult mice. To circumvent this problem, we constructed a conditional knockout allele of c/ebp alpha by using the Cre/loxP recombination system. Homozygous c/ebp-loxP mice, (c/ebp alpha(fl/fl);fl, flanked by loxP sites) were found to be indistinguishable from their wild-type counterparts. However, when Cre recombinase was delivered to hepatocytes of adult c/ebp alpha(fl/fl) mice by infusion of a recombinant adenovirus carrying the cre gene, more than 80% of the c/ebp alpha(fl/fl) genes were deleted specifically in liver and C/EBP alpha expression was reduced by 90%. This condition resulted in a reduced level of bilirubin UDP-glucuronosyltransferase expression in the liver. After several days, the knockout mice developed severe jaundice due to an increase in unconjugated serum bilirubin. The expression of genes encoding phosphoenolpyruvate carboxykinase, glycogen synthase, and factor IX was also strongly reduced in adult conditional-knockout animals, while the expression of transferrin, apolipoprotein B, and insulin-like growth factor I genes was not affected. These results establish C/EBP alpha as an essential transcriptional regulator of genes encoding enzymes involved in bilirubin detoxification and gluconeogenesis in adult mouse liver.

Citing Articles

Transcription networks in liver development and acute liver failure.

Feng R, Liebe R, Weng H Liver Res. 2025; 7(1):47-55.

PMID: 39959701 PMC: 11791834. DOI: 10.1016/j.livres.2022.11.010.

Hepatocyte-specific CCAAT/enhancer binding protein α restricts liver fibrosis progression.

Yan T, Yan N, Xia Y, Sawaswong V, Zhu X, Dias H J Clin Invest. 2024; 134(7).

PMID: 38557493 PMC: 10977981. DOI: 10.1172/JCI166731.

TET2 lesions enhance the aggressiveness of CEBPA-mutant acute myeloid leukemia by rebalancing GATA2 expression.

Heyes E, Wilhelmson A, Wenzel A, Manhart G, Eder T, Schuster M Nat Commun. 2023; 14(1):6185.

PMID: 37794021 PMC: 10550934. DOI: 10.1038/s41467-023-41927-x.

Case report: promoter activity may define the alveolar macrophage dichotomy.

Vo T, Saini Y Front Immunol. 2022; 13:1050494.

PMID: 36578483 PMC: 9791191. DOI: 10.3389/fimmu.2022.1050494.

Identification of mutations that cooperate with defects in B cell transcription factors to initiate leukemia.

Heltemes-Harris L, Hubbard G, LaRue R, Munro S, Yang R, Henzler C Oncogene. 2021; 40(43):6166-6179.

PMID: 34535769 PMC: 8556320. DOI: 10.1038/s41388-021-02012-z.

References

Lee Y, Yano M, Liu S, Matsunaga E, Johnson P, Gonzalez F . A novel cis-acting element controlling the rat CYP2D5 gene and requiring cooperativity between C/EBP beta and an Sp1 factor. Mol Cell Biol. 1994; 14(2):1383-94. PMC: 358493. DOI: 10.1128/mcb.14.2.1383-1394.1994. View

Theisen M, Behringer R, Cadd G, Brinster R, McKnight G . A C/EBP-binding site in the transferrin promoter is essential for expression in the liver but not the brain of transgenic mice. Mol Cell Biol. 1993; 13(12):7666-76. PMC: 364838. DOI: 10.1128/mcb.13.12.7666-7676.1993. View

Bosma P, Seppen J, Goldhoorn B, Bakker C, Oude Elferink R, Chowdhury J . Bilirubin UDP-glucuronosyltransferase 1 is the only relevant bilirubin glucuronidating isoform in man. J Biol Chem. 1994; 269(27):17960-4. View

OBrien R, Lucas P, Yamasaki T, Noisin E, GRANNER D . Potential convergence of insulin and cAMP signal transduction systems at the phosphoenolpyruvate carboxykinase (PEPCK) gene promoter through CCAAT/enhancer binding protein (C/EBP). J Biol Chem. 1994; 269(48):30419-28. View

OBrien R, Noisin E, Suwanichkul A, Yamasaki T, Lucas P, Wang J . Hepatic nuclear factor 3- and hormone-regulated expression of the phosphoenolpyruvate carboxykinase and insulin-like growth factor-binding protein 1 genes. Mol Cell Biol. 1995; 15(3):1747-58. PMC: 230399. DOI: 10.1128/MCB.15.3.1747. View

Kay M, Graham F, Leland F, Woo S . Therapeutic serum concentrations of human alpha-1-antitrypsin after adenoviral-mediated gene transfer into mouse hepatocytes. Hepatology. 1995; 21(3):815-9. View

Yang Y, Li Q, Ertl H, Wilson J . Cellular and humoral immune responses to viral antigens create barriers to lung-directed gene therapy with recombinant adenoviruses. J Virol. 1995; 69(4):2004-15. PMC: 188865. DOI: 10.1128/JVI.69.4.2004-2015.1995. View

Nolten L, van Schaik F, Steenbergh P, Sussenbach J . Expression of the insulin-like growth factor I gene is stimulated by the liver-enriched transcription factors C/EBP alpha and LAP. Mol Endocrinol. 1994; 8(12):1636-45. DOI: 10.1210/mend.8.12.7708053. View

Anton M, Graham F . Site-specific recombination mediated by an adenovirus vector expressing the Cre recombinase protein: a molecular switch for control of gene expression. J Virol. 1995; 69(8):4600-6. PMC: 189258. DOI: 10.1128/JVI.69.8.4600-4606.1995. View

10.

Harper J, Elledge S, Keyomarsi K, Dynlacht B, Tsai L, Zhang P . Inhibition of cyclin-dependent kinases by p21. Mol Biol Cell. 1995; 6(4):387-400. PMC: 301199. DOI: 10.1091/mbc.6.4.387. View

11.

Drazan K, Csete M, da Shen X, Bullington D, Cottle G, Busuttil R . Hepatic function is preserved following liver-directed, adenovirus-mediated gene transfer. J Surg Res. 1995; 59(2):299-304. DOI: 10.1006/jsre.1995.1168. View

12.

Wang N, Finegold M, Bradley A, Ou C, Abdelsayed S, Wilde M . Impaired energy homeostasis in C/EBP alpha knockout mice. Science. 1995; 269(5227):1108-12. DOI: 10.1126/science.7652557. View

13.

Rodenburg R, Teertstra W, Holthuizen P, Sussenbach J . Postnatal liver-specific expression of human insulin-like growth factor-II is highly stimulated by the transcriptional activators liver-enriched activating protein and CCAAT/enhancer binding protein-alpha. Mol Endocrinol. 1995; 9(4):424-34. DOI: 10.1210/mend.9.4.7659086. View

14.

Owens I, Ritter J . Gene structure at the human UGT1 locus creates diversity in isozyme structure, substrate specificity, and regulation. Prog Nucleic Acid Res Mol Biol. 1995; 51:305-38. DOI: 10.1016/s0079-6603(08)60882-x. View

15.

Graham F, Prevec L . Methods for construction of adenovirus vectors. Mol Biotechnol. 1995; 3(3):207-20. DOI: 10.1007/BF02789331. View

16.

Fang B, Eisensmith R, Li X, Finegold M, Shedlovsky A, Dove W . Gene therapy for phenylketonuria: phenotypic correction in a genetically deficient mouse model by adenovirus-mediated hepatic gene transfer. Gene Ther. 1994; 1(4):247-54. View

17.

Nolten L, Steenbergh P, Sussenbach J . Hepatocyte nuclear factor 1 alpha activates promoter 1 of the human insulin-like growth factor I gene via two distinct binding sites. Mol Endocrinol. 1995; 9(11):1488-99. DOI: 10.1210/mend.9.11.8584026. View

18.

Granner D, Andreone T, Sasaki K, Beale E . Inhibition of transcription of the phosphoenolpyruvate carboxykinase gene by insulin. Nature. 1983; 305(5934):549-51. DOI: 10.1038/305549a0. View

19.

Sasaki K, Cripe T, Koch S, Andreone T, Petersen D, Beale E . Multihormonal regulation of phosphoenolpyruvate carboxykinase gene transcription. The dominant role of insulin. J Biol Chem. 1984; 259(24):15242-51. View

20.

Huppi K, Siwarski D, Dosik J, Michieli P, Chedid M, Reed S . Molecular cloning, sequencing, chromosomal localization and expression of mouse p21 (Waf1). Oncogene. 1994; 9(10):3017-20. View